Grand opening of new Dengue vaccine manufacturing plant in Singen, Germany
Learn more
Raising standards in home parenteral nutrition
Understanding the impact of ADHD among adults
Dow Jones Sustainability Index Recognizes Takeda's Efforts in Sustainability
Enhancing our Commitment to African Development through Access to Medicines - Takeda at TICAD7
Discourse and progress in intestinal failure care
Takeda Moves to Transform Global Child Health Research with the London School of Hygiene & Tropical Medicine
Grand opening of Takeda’s new production facility, Grange Castle, Ireland
2019 Innovators in Science Award Winners Celebrated for Regenerative Medicine Research
Takeda breaks ground on a state of the art facility in Osaka, Japan
Strengthening Takeda’s Global Reach by Sustaining Core Values
Deepening Our Commitment to Research with State-of-the-Art Facility in San Diego, California
CEO Christophe Weber on Why Takeda’s Unique Corporate Governance Structure Works
Andy Plump on pushing the boundaries of science within the “new” Takeda R&D community
Ramona Sequeira, President of Takeda's U.S. Business Unit, on the many opportunities that lie ahead for the “new” Takeda
Embracing diversity and inclusion in an expanding global workplace
Celebrating Our New Global Reach
Takeda’s Transformation: The Next Chapter
Novel access solutions for novel medicines
Perspectives on confronting and embracing disruptions in healthcare
Research study highlights that it really does help to walk in a patient’s shoes
R&D events at Takeda highlight our transformation into a leading, global pharmaceutical company
LEARN MORE
Life at Takeda Videos
Shonan Health Innovation Park Grand Opening
Takeda’s CSR in Action: Helping Save Children's Lives Through Immunization
2017 Winners and Finalists Honored at Awards Ceremony at NYAS in New York City
Takeda Exhibits Innovation Park Vision at Bio Japan 2017
Strengthening our global production network in Oranienburg
#InTheirShoes: What it’s like to be an IBD patient – how we’ve approached it
Takeda Recognized for Commitment to Quality
Inflammatory Bowel Disease (IBD) Patient Engagement in R&D
Digital Innovation for Better Disease Management in Inflammatory Bowel Disease (IBD)
Neuroscience Research & Development at Takeda
Let's Turn This Around
Micro Size, Macro Opportunity: Looking for New Applications of our Microbiome
Leveraging the Superpowers of People Living with IBD to Create the First IBD Super Hero Team
Reports&Publications
Sustainable Value Report
Quarterly Results, Broker Conferences, Special IR Events FY2018 (April 2018-March 2019）
